Identification solutions manufacturer Brady (NYSE:BRC) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 7.7% year on year to $384.1 million. Its non-GAAP profit of ...
As global manufacturers recalibrate their growth strategies, India is emerging as more than just a high-potential sales market.
QINGPU, SHANGHAI, CHINA, February 12, 2026 /EINPresswire.com/ -- Introduction: Meeting Global Innovation Where It Will ...
Telix Pharma submits marketing authorization application in Europe for TLX101-Px for imaging brain cancer: Melbourne, Australia Friday, February 20, 2026, 16:00 Hrs [IST] Telix Ph ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results